Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1274 results for "sun pharma"

Markets resilient; defensives lose sheen
Business Standard

Markets resilient; defensives lose sheen

Sun Pharma, ITC, Tata Motors down 1-2% were the top losers SI Reporter | Mumbai September 1, 2014 Last Updated at 14:30 IST Benchmark indices continue to maintain the upbeat trend with capital goods and bank shares leading the gains on better-than-expected ... Business Standard, 2 hours ago
Markets firm; PSU banks slip after EOW uncovers fraud Business Standard India, 4 days ago
Smallcaps rally while markets take a breather Business Standard India, 1 week ago

94 images for sun pharma

Financial Express, 4 days ago
Deccan Chronicle, 4 days ago, 3 days ago, 4 days ago
Financial Express, 2 weeks ago, 2 weeks ago
Financial Express, 2 weeks ago
Business Today India, 2 weeks ago
Deccan Chronicle, 2 weeks ago
Business Today India, 4 days ago

Nifty starts Sept series at record high; Maruti up 3%

LT, Maruti, Hero MotoCorp, Cipla and Gail are top gainers in the Sensex. Among the losers are Tata MotoCorp, Sun Pharma, BHEL, ITC and HDFC.
 Money Control4 hours ago Sensex rallies over 100 points; metals, pharma gain  Economic Times5 days ago Sensex surges 200 pts; SBI, Arvind most active shares  Money Control1 week ago Nifty at record high, Sensex up 100 pts; Maruti top gainer  Money Control1 week ago
Money Control

Here are top 10 stocks to keep an eye on Sep 1

Here are top 10 stocks to keep an eye on Sep 1 - Sun TV, Spicejet, JSPL, Hindalco, Coal India, Cipla, Wockhardt, Natco Pharma, Bharti Airtel and Bajaj Electricals.
 Money Control7 hours ago Stocks in news: ONGC, Adani Power, Torrent Pharma, MCX, ITD  Moneycontrol.com4 days ago Stocks in news: BHEL, Sun Pharma, ONGC, NMDC, Essar Oil  Money Control2 weeks ago Here are top 10 stocks to watch on August 8  Money Control3 weeks ago
Business Standard

Top five Sensex firms add Rs 31k cr in market valuation

TCS emerges as the biggest gainer; CIL, Infosys, HDFC Bank, SBI and Sun Pharma suffer losses Press Trust of India | New Delhi August 31, 2014 Last Updated at 10:45 IST The combined market valuation of five of the top-10 blue-chip Sensex companies surged by Rs ...
 Business Standard1 day ago Top 5 Sensex cos add Rs 31,165 cr in market cap  Economic Times1 day ago Top 5 Sensex firms gain Rs 31,165 crore in market value  Hindu Business Line1 day ago Top firms add Rs 31,164.67 cr in market valuation  ZeeNews.com1 day ago
Money Today

CCI raises concern over Sun- Ranbaxy deal

In April this year, Sun Pharma and Ranbaxy had announced a $4-billion deal that would create one of the top five largest speciality generics company in the world. Chawla said the major issues related to the deal are with regard to molecules market. "The major ...
 Money Today3 days ago Sun-Ranbaxy merger: competition panel demands more details  Domain-B4 days ago Sun Pharma-Ranbaxy CCI probe in new phase [Mint, New Delhi :: ]  BusinessWeek4 days ago CCI expands probe into Sun Pharma-Ranbaxy deal  Money Control4 days ago

Sun Pharma, Ranbaxy slip; CCI asks more details of merger

Sun Pharma and Ranbaxy, which had announced a USD 4-billion deal in April this year, were asked by CCI on Wednesday to make public details of their proposed transaction in a "prescribed format" within 10 working days.
 Money Control4 days ago CCI asks Ranbaxy and Sun Pharma for details on proposed merger  Myiris4 days ago Sun Pharma slips in volatile trade  Business Standard4 days ago Sun Pharma receives communication from CCI  Money Control4 days ago
Business Standard

What peak? Analysts see pharma stocks quoting 60x!

MUMBAI: The pharmaceuticals stocks have surprised many with spectacular rally even as the market rally was led by high beta cyclical stocks after the new government took charge. The BSE Healthcare Index has given returns of massive 28 per cent ...
 Economic Times4 days ago Sun Pharma up over 4% on NSE  Hindu Business Line1 week ago Pharma stocks extend their gains on BSE  Hindu Business Line1 week ago Pharma stocks outperform equity benchmarks, rally 2-14%  Moneycontrol.com1 week ago

Hold Sun Pharma, says Ashu Madan

Ashu Madan of Religare Securities advises holding Sun Pharmaceutical Industries.
 Money Control6 days ago China's Luye Pharma founder soars into pharma's billionaire echelon  FiercePharma5 days ago TGP shakes up pharma market  Philippine Daily Inquirer1 week ago Hold Ranbaxy Laboratories, says Ashu Madan  Moneycontrol.com1 week ago

Competition Commission extends Sun Pharma-Ranbaxy probe to new stage

Sun Pharma agreed to buy Ranbaxy for $3.2 billion in stock from its Japanese parent Daiichi Sankyo in a deal that would create the world's fifth largest generic drugmaker. Photo: Bloomberg New Delhi: India's antitrust regulator has ordered a ...
 Livemint.com3 days ago Sun Pharma to buy Ranbaxy for USD 4 billion in all-share deal  NewKerala.com1 week ago

CCI direction: Sun, Ranbaxy to publish details of merger

Sun Pharma and Ranbaxy, which had entered into a $4-billion deal in April, have told the Bombay Stock Exchange that they will publish the details of the proposed combination within 10 working days. The decision is in compliance of a recent direction ...
 Hindu Business Line3 days ago Sun-ranbaxy deal gets nod  Asian Age1 month ago Sun Pharma-Ranbaxy merger gets BSE, NSE thumbs-up  Business Standard1 month ago Indian bourses' nod for Sun Pharma-Ranbaxy deal  Rediff.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sun pharma
Get updated on latest news & your favorite topics right in your inbox!
More     Less